Filing Details
- Accession Number:
- 0001553350-21-001066
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-11-19 08:48:50
- Reporting Period:
- 2021-11-18
- Accepted Time:
- 2021-11-19 08:48:50
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1293818 | Opgen Inc | OPGN | Services-Medical Laboratories (8071) | 061614015 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1808932 | Oliver Schacht | C/O Opgen, Inc. 9717 Key West Ave. Suite 100 Rockville MD 20850 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-11-18 | 10,000 | $1.50 | 30,000 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 5,000 | Indirect | As custodian for minor son |
Footnotes
- The shares of Common Stock were purchased in a series of trades at prices ranging from $1.49 per share to $1.50 per share having a weighted average of $1.496 per share. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.